Park Medi World Reports Q2 Revenue Of ₹510 Crore And Net Profit Of ₹52.1 Crore

Market snapshot: Park Medi World Limited reported its Q2 financial results, delivering a robust top-line expansion alongside margin pressure. Consolidated revenue increased to ₹510 crore, up from ₹410 crore in the year-ago quarter. However, consolidated net profit declined to ₹52.1 crore against ₹73.6 crore YoY as EBITDA margins compressed from 27.5% to 20%.

Data Snapshot

• Consolidated revenue grew to ₹510 crore from ₹410 crore in the prior-year quarter.
• Consolidated net profit contracted to ₹52.1 crore compared with ₹73.6 crore YoY.
• EBITDA decreased to ₹101 crore from ₹113 crore in the corresponding quarter last year.
• EBITDA margin stood at 20% against 27.5% recorded in the year-ago period.

What's Changed

• Consolidated revenue expanded by ≈24.39% YoY (derived: ₹510 cr vs ₹410 cr).
• Consolidated net profit declined by ≈29.21% YoY (derived: ₹52.1 cr vs ₹73.6 cr).
• EBITDA contracted by ≈10.62% YoY (derived: ₹101 cr vs ₹113 cr).
• EBITDA margin compressed by 750 basis points YoY (derived: 20% vs 27.5%).

Key Takeaways

• Strong demand for hospital services drove top-line growth of ≈24.39% YoY to ₹510 crore.
• Operational profitability was impacted by higher capacity addition costs, driving EBITDA margin down to 20%.
• Net profit fell to ₹52.1 crore due to margin contraction and operational overheads associated with facility expansions.

SAHI Perspective

Park Medi World is undergoing a classic operational absorption cycle. Top-line revenue expansion of ≈24.39% YoY reflects solid patient turnover and bed utilization across North Indian healthcare clusters. However, ongoing greenfield launches and brownfield hospital expansions typically carry higher initial fixed costs, temporarily compressing EBITDA margins from 27.5% to 20%. As new bed capacity ramps up, operating leverage should normalize profitability over medium-term horizons.

Market Implications

The divergence between revenue growth and margin contraction suggests near-term earnings re-rating risks. Investors will closely monitor management guidance during upcoming investor calls regarding bed occupancy rates and cost rationalization measures across regional hospital networks.

Trading Signals

Market Bias: Neutral

Revenue growth of ≈24.39% YoY to ₹510 crore demonstrates strong underlying healthcare demand, but a 750 bps contraction in EBITDA margin to 20% and a ≈29.21% decline in net profit to ₹52.1 crore indicate near-term margin pressure.

Overweight: Healthcare & Hospitals

Trigger Factors:

• Recovery of EBITDA margins toward historical 25%+ levels
• Occupancy ramp-up at expanded regional hospital facilities
• Sequential stability in operational expenses per operating bed

Time Horizon: Near-term (0-3 months)

Industry Context

Private healthcare platforms in North India continue to experience robust inpatient and outpatient volume growth. Higher capital expenditure toward greenfield hospital commissioning often leads to temporary margin compression before operating leverage matures.

Key Risks to Watch

• Gestational drag from newly added hospital beds delaying margin recovery
• Inflationary pressure on doctor remuneration and medical supplies
• Regulatory revisions in government scheme tariffs impacting specialized care margins

Recent Developments

Park Medi World announced the rescheduling of its analyst and institutional investor conference call to November 14, 2026, to discuss the Q2 FY27 financial performance. Earlier in April 2026, the company launched a multi-super specialty greenfield hospital in Panchkula, Haryana, expanding its private healthcare infrastructure footprint across the Tricity region.

Closing Insight

While Park Medi World continues to build regional healthcare scale through bed additions, disciplined execution on operational efficiency remains vital to translating top-line momentum into bottom-line earnings recovery.

High Performance Trading with SAHI.